Product Information
ROFLUMILAST 500 MCG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3204 per EA under NDC 59651027530. Its NADAC has been published 157 times since Jun 28, 2023.
Strength
500 ug/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651027530
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROFLUMILASTApproval Type
Generic (ANDA)
FDA Application
ANDA213298On Market Since
4/17/2023
Pharmacological Classes
Price Statistics
The NADAC for ROFLUMILAST 500 MCG TABLET has been published 157 times since Jun 28, 2023, and over the history we have for it it has declined 54.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3204 per EA |
|---|---|
| All-time high | $0.7070 (Jul 12, 2023) |
| All-time low | $0.2563 (Nov 20, 2024) |
| 52-week high | $0.3654 |
| 52-week low | $0.3118 |
| Median price | $0.3542 |
| Average price | $0.3694 |
| Largest weekly change | +40.4% (Jun 19, 2024) |
| Weeks tracked | 157 |
| Tracking since | Jun 28, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROFLUMILAST 500 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROFLUMILAST 500 MCG TABLET, manufactured by Aurobindo Pharma Limited, is $0.3204 per EA (NDC 59651027530), effective Jun 24, 2026.
How has the price of ROFLUMILAST 500 MCG TABLET changed over time?
Over the history we have for it, the NADAC for ROFLUMILAST 500 MCG TABLET has declined 54.7%. It has been tracked across 157 weekly CMS publications since Jun 28, 2023.
What are the highest and lowest recorded NADAC prices for ROFLUMILAST 500 MCG TABLET?
Since Jun 28, 2023, the NADAC for ROFLUMILAST 500 MCG TABLET has ranged from a low of $0.2563 (Nov 20, 2024) to a high of $0.7070 (Jul 12, 2023), with a median of $0.3542 per EA.
Are there cheaper alternatives to ROFLUMILAST 500 MCG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ROFLUMILAST 500 MCG TABLET, but none are currently priced below it.
Who manufactures ROFLUMILAST 500 MCG TABLET?
ROFLUMILAST 500 MCG TABLET (NDC 59651027530) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification